U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
109281
Substance Class Protein
Created
by admin
on Sat Jun 26 17:20:36 UTC 2021
Edited
by admin
on Sat Jun 26 17:20:36 UTC 2021
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
06P3KLK2J8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLOFITAMAB
INN   USAN  
Official Name English
IMMUNOGLOBULIN G1 (149-GLUTAMIC ACID,215-GLUTAMIC ACID,461-ALANINE,462-ALANINE,556-GLYCINE,581-CYSTEINE,593-TRYPTOPHAN), ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL RG6026 VH-CH1 FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 10-AMINO ACID
Common Name English
GLOFITAMAB [INN]
Common Name English
RG-6026
Code English
GLOFITAMAB [USAN]
Common Name English
ANTI-CD20/CD3 BISPECIFIC MONOCLONAL ANTIBODY RO7082859
Common Name English
RO7082859
Code English
RO-7082859
Code English
IMMUNOGLOBULIN G1-LAMBDA/KAPPA WITH DOMAIN CROSS-OVER, ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)) MONOCLONAL ANTIBODY, BISPECIFIC, TRIVALENTGAMMA-LAMBDA HEAVY CHAIN
Common Name English
GLOFITAMAB [WHO-DD]
Common Name English
Code System Code Type Description
INN
11145
Created by admin on Sat Jun 26 17:20:36 UTC 2021 , Edited by admin on Sat Jun 26 17:20:36 UTC 2021
PRIMARY
CAS
2229047-91-8
Created by admin on Sat Jun 26 17:20:36 UTC 2021 , Edited by admin on Sat Jun 26 17:20:36 UTC 2021
PRIMARY
FDA UNII
06P3KLK2J8
Created by admin on Sat Jun 26 17:20:36 UTC 2021 , Edited by admin on Sat Jun 26 17:20:36 UTC 2021
PRIMARY
NCI_THESAURUS
C148486
Created by admin on Sat Jun 26 17:20:36 UTC 2021 , Edited by admin on Sat Jun 26 17:20:36 UTC 2021
PRIMARY
From To
1_22 1_96
1_146 1_202
1_255 1_323
1_371 1_427
1_447 5_232
1_453 2_228
1_456 2_231
1_488 1_548
1_222 3_219
1_594 1_652
2_22 2_96
2_146 2_202
2_222 4_219
2_263 2_323
2_369 2_427
1_581 2_351
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
5_22 5_98
5_152 5_212
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_524
N 2_299
Related Record Type Details
B-LYMPHOCYTE ANTIGEN CD20
TARGET->LIGAND
T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN
TARGET -> ACTIVATOR
Related Record Type Details
GLOFITAMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966